Mcpherson'S Limited (MCP) AI Stock Analysis

• Market Cap: AU$25.91M
• Dividend Yield: N/A
• Average Volume (3M): 451.79K
• Price to Earnings (P/E): ―
• Beta (1Y): 0.63
• Revenue Growth: -3.91%
• EPS Growth: 5.94%
• Country: AU
• Employees: 876
• Sector: Consumer Defensive
• Sector Strength: 42
• Industry: Household & Personal Products
• EPS (TTM): -0.02
• Shares Outstanding: 143,949,140
• 10 Day Avg. Volume: 1,155,699
• 30 Day Avg. Volume: 451,786
• PEG Ratio: -0.24
• Price to Book (P/B): 0.45
• Price to Sales (P/S): 0.23
• P/FCF Ratio: 20.71
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 46 Neutral
• Price Target: AU$0.18 ▼(-26.67% Downside)
• Action: Reiterated Date: 11/18/25
• Date: Action: Reiterated 11/18/25

The overall stock score is primarily impacted by financial performance challenges, including persistent profitability issues and cash flow concerns. Technical analysis indicates a bearish trend, and valuation metrics are weak due to a negative P/E ratio and lack of dividend yield. The absence of earnings call data and corporate events means these factors did not influence the score.

Positive Factors

Revenue Growth

Sustained double-digit top-line growth (19.9% y/y and a 24.1% uptick in the latest period) indicates durable demand for McPherson's branded health and beauty products. Over 2-6 months this supports scale benefits, retail shelf presence and bargaining power with suppliers and channels.

Strong Gross Margin

A 57.9% gross margin provides structural protection versus input and freight inflation and signals pricing power or favorable sourcing. For a brand-management and distribution model this margin supports reinvestment in marketing and cushioning of operating cost volatility over the medium term.

Low Leverage

Very low debt-to-equity (0.10) gives McPherson's financial flexibility to fund working capital, marketing or M&A without heavy interest burden. This balance sheet strength lowers solvency risk and preserves capacity to navigate retail seasonality and supply-chain disruptions for months ahead.

Negative Factors

Negative Profitability

Persistent negative net profit, EBIT and EBITDA margins indicate structural operating inefficiencies or elevated fixed costs versus current revenue mix. Over the medium term this erodes retained earnings, limits reinvestment and makes it harder to convert sales growth into sustainable shareholder returns.

Declining Free Cash Flow

A 68.6% drop in free cash flow is a durable concern: it reduces capacity to invest in brands, meet working capital needs or absorb shocks. If sustained, weak FCF forces reliance on external financing or asset sales, constraining strategic initiatives and operational stability over months.

Poor Cash Conversion & Negative ROE

Low conversion of earnings into cash combined with negative ROE shows the business struggles to generate real economic returns. Structurally, this limits dividend capacity and capital allocation effectiveness, reducing investor confidence and hampering long-term value creation.

Mcpherson'S Limited Business Overview & Revenue Model

Company Description

McPherson's Limited provides health, wellness, and beauty products in Australia, New Zealand, Asia, and internationally. It offers beauty care, hair care, skin care, and personal care items, including facial wipes, cotton pads, and foot comfort products; and vitamins and supplements, as well as various kitchen essentials, such as baking papers, cling wraps, and aluminium foils. The company sells its products primarily under the owned brands, including Dr. LeWinn's, A'kin, Manicare, Lady Jayne, Swisspers, Multix, Fusion Health, Oriental Botanicals, Moosehead, and Maseur. The company was founded in 1860 and is based in Kingsgrove, Australia.

How the Company Makes Money

McPherson's makes money primarily by selling consumer health, beauty and wellness products into wholesale and retail channels. Revenue is generated from (1) sales of branded products the company owns or manages (brand development, marketing and category management drive demand; margins are earned on the spread between selling price and product, packaging, logistics and marketing costs) and (2) distribution/wholesaling activities where McPherson's supplies products to retailers and pharmacies, earning a wholesale margin. Earnings are influenced by retail sell-through, pricing and promotional activity, input and freight costs, and the effectiveness of sourcing and supply-chain management. Specific details on material partnerships, customer concentration, or segment revenue breakdown were not available (null).

Mcpherson'S Limited Financial Statement Overview

Summary

Mcpherson's Limited shows mixed financial health with strong revenue growth but persistent profitability issues. The balance sheet reflects improved leverage but negative returns on equity. Cash flow challenges persist, with declining free cash flow and low cash conversion ratios, indicating potential liquidity concerns.

Income Statement

Mcpherson's Limited has experienced fluctuating revenue growth, with a notable 24.14% increase in the latest period, but has consistently faced negative net profit margins, indicating ongoing profitability challenges. The gross profit margin improved significantly to 57.88%, but negative EBIT and EBITDA margins highlight operational inefficiencies.

Balance Sheet

The company's debt-to-equity ratio has improved to 0.10, reflecting better leverage management. However, the return on equity remains negative, indicating challenges in generating returns for shareholders. The equity ratio is stable, suggesting a balanced asset structure.

Cash Flow

Free cash flow has declined significantly by 68.55%, raising concerns about cash generation. The operating cash flow to net income ratio is low, indicating potential issues in converting income into cash. However, the free cash flow to net income ratio is relatively strong, suggesting some efficiency in cash utilization.

Breakdown	TTM	Jun 2025	Jun 2024	Jun 2023	Jun 2022	Jun 2021
Income Statement
Total Revenue	134.24M	138.99M	144.63M	155.23M	214.00M	200.50M
Gross Profit	62.31M	80.45M	35.09M	47.77M	90.80M	87.48M
EBITDA	-6.83M	-6.99M	-4.92M	3.10M	7.44M	5.98M
Net Income	-16.42M	-15.04M	-15.99M	-5.06M	333.00K	-5.37M
Balance Sheet
Total Assets	116.49M	117.21M	146.90M	190.06M	215.76M	199.59M
Cash, Cash Equivalents and Short-Term Investments	12.74M	9.48M	24.77M	7.03M	13.14M	7.35M
Total Debt	7.07M	7.30M	19.85M	25.45M	29.38M	20.93M
Total Liabilities	45.97M	44.23M	57.26M	80.61M	94.95M	84.96M
Stockholders Equity	70.52M	72.98M	89.64M	109.45M	120.81M	114.62M
Cash Flow
Free Cash Flow	6.08M	1.57M	9.64M	4.70M	16.32M	168.00K
Operating Cash Flow	6.31M	2.21M	12.34M	6.55M	18.57M	2.69M
Investing Cash Flow	-1.85M	-3.62M	16.29M	-1.85M	-2.25M	-31.80M
Financing Cash Flow	-3.54M	-13.91M	-10.90M	-10.91M	-10.59M	29.42M

Mcpherson'S Limited Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 0.24
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AU:MCP, the sentiment is Negative. The current price of 0.24 is above the 20-day moving average (MA) of 0.19, above the 50-day MA of 0.20, and below the 200-day MA of 0.25, indicating a bearish trend. The MACD of >-0.01 indicates Negative momentum. The RSI at 40.98 is Neutral, neither overbought nor oversold. The STOCH value of 40.00 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for AU:MCP.

Mcpherson'S Limited Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
S66	63 Neutral	AU$26.33M	21.25	14.06%	1.54%	6.89%	607.27%
Sector *	62 Neutral	$20.33B	14.63	-3.31%	3.23%	1.93%	-12.26%
ABY	58 Neutral	AU$37.58M	157.84	0.80%	―	1.58%	-65.09%
MCP	46 Neutral	AU$25.91M	-3.77	-20.06%	―	-3.91%	5.94%
PTL	46 Neutral	AU$5.28M	-5.68	-10.69%	―	-25.16%	77.62%
CCX	46 Neutral	AU$32.74M	-3.00	-16.89%	―	2.35%	95.03%
SKN	45 Neutral	AU$18.00M	-0.26	2542.90%	―	12.92%	34.21%

Mcpherson'S Limited Corporate Events

McPherson’s details flexible on-market share buy-back activity

McPherson’s Limited has lodged a daily notification with the ASX outlining activity under its on-market share buy-back program for its ordinary fully paid shares, identified under code MCP, as at 17 March 2026. The company currently has 143,949,141 shares on issue in the relevant class and has appointed Third Party Platform Pty Ltd to execute buy-back transactions on its behalf.

Under the disclosed parameters, McPherson’s does not intend to specify either a minimum or maximum number of shares to be repurchased, giving it flexibility to adjust buy-back volumes in response to market conditions and capital management needs. This structure suggests an open-ended approach to returning capital or managing the share base, potentially affecting liquidity, earnings per share dynamics and the ownership profile for existing shareholders over time.

The most recent analyst rating on (AU:MCP) stock is a Hold with a A$0.17 price target. To see the full list of analyst forecasts on Mcpherson’S Limited stock, see the AU:MCP Stock Forecast page.

McPherson’s Launches Flexible On‑Market Share Buy‑Back

McPherson’s Limited has lodged a daily notification with the ASX confirming it is conducting an on‑market share buy‑back of its ordinary fully paid shares. The buy‑back applies to a total on‑issue capital of 143,949,141 shares, with execution to be carried out through broker Third Party Platform Pty Ltd and without a specified minimum or maximum number of shares to be repurchased.

The absence of defined buy‑back volume parameters suggests a flexible capital management approach, allowing McPherson’s to adjust purchase levels in response to market conditions. This structure may support the company’s share price and signal confidence in its valuation, while offering existing shareholders potential benefits through improved capital efficiency and future earnings per share accretion.

The most recent analyst rating on (AU:MCP) stock is a Hold with a A$0.17 price target. To see the full list of analyst forecasts on Mcpherson’S Limited stock, see the AU:MCP Stock Forecast page.

McPherson’s Unveils $2 Million On-Market Share Buy-Back as Part of Capital Management Drive

McPherson’s Limited, a Sydney-based ASX-listed supplier of health and beauty products under brands such as Manicare, Swisspers and Dr. LeWinn’s, targets consumers through pharmacy, grocery, health food and online retail channels. The company continues to position its core brands at the centre of its growth strategy, leveraging multiple distribution channels to deepen market reach.

The company has announced an on-market share buy-back of up to $2 million to be conducted over the next 12 months starting in March 2026. The board frames the buy-back as part of a broader capital allocation framework aimed at returning capital to shareholders, optimising capital management and enhancing shareholder value, while preserving flexibility for future growth and operating within regulatory limits that avoid the need for shareholder approval.

The most recent analyst rating on (AU:MCP) stock is a Hold with a A$0.19 price target. To see the full list of analyst forecasts on Mcpherson’S Limited stock, see the AU:MCP Stock Forecast page.

McPherson’s Sets Webcast to Present 1H26 Financial Results

McPherson’s Limited, a Sydney-based ASX-listed supplier of health and beauty products built around brands such as Manicare, Swisspers, Lady Jayne, Dr. LeWinn’s and Fusion Health, targets consumers via pharmacy, grocery, health food and online channels. The company has announced that its financial results for the half year ended 31 December 2025 will be presented in a webcast and conference call on 25 February 2026, giving shareholders an opportunity to hear directly from senior management and pose questions, which may provide fresh insight into trading performance and strategic direction for stakeholders.

The briefing will be hosted by Chief Executive Officer and Managing Director Brett Charlton alongside Chief Financial Officer Mark Sherwin, underscoring the importance of the half-year update to the market. By engaging investors through both teleconference and webcast, McPherson’s is aiming to maintain transparency and strengthen investor relations at a time when performance in the health and beauty sector and the trajectory of its core brands remain key to its market positioning.

The most recent analyst rating on (AU:MCP) stock is a Hold with a A$0.19 price target. To see the full list of analyst forecasts on Mcpherson’S Limited stock, see the AU:MCP Stock Forecast page.

McPherson’s trims costs, lifts cash as new operating model beds down despite 1H loss

McPherson’s reported revenue from continuing operations of $66.0 million for the half year to 31 December 2025, a 6.7% decline, but maintained largely stable core brand sales at $61.9 million as Manicare and Swisspers delivered solid growth while Dr LeWinn’s and Fusion Health lagged. The shift to a new operating model reduced fixed costs, lifting underlying EBITDA 10.6% to $2.2 million and supporting a net cash position of $12.6 million, despite a statutory net loss of $2.3 million driven by a non-cash impairment and one-off items.

Management highlighted that the transition to pharmacy wholesalers, SKU rationalisation, and logistics outsourcing caused temporary revenue and supply disruptions, particularly for Dr LeWinn’s and Fusion Health, but said corrective actions and restored stock levels should support gradual improvement in the second half. The board opted against paying a dividend but authorised an on-market share buyback of up to A$2.0 million, signalling confidence in the company’s strategy and the scalability of its new operating model for future growth and shareholder returns.

The most recent analyst rating on (AU:MCP) stock is a Hold with a A$0.19 price target. To see the full list of analyst forecasts on Mcpherson’S Limited stock, see the AU:MCP Stock Forecast page.

McPherson’s Announces Departure of Director Jane McKellar and Discloses Final Shareholding

McPherson’s Limited has announced the cessation of director Jane Matisse McKellar from the company’s board effective 31 January 2026, in accordance with ASX listing rule disclosure requirements. At the time of her departure, McKellar held a total of 11,533 ordinary shares in McPherson’s Limited, with no additional indirect holdings or interests in related contracts disclosed, providing investors with clarity on her remaining equity stake and potential ongoing alignment with the company’s performance.

The most recent analyst rating on (AU:MCP) stock is a Hold with a A$0.23 price target. To see the full list of analyst forecasts on Mcpherson’S Limited stock, see the AU:MCP Stock Forecast page.